Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H22BrF3N2O5S |
Molecular Weight | 539.363 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(Br)=C(C=C1OC)S(=O)(=O)NC2=CC(O[C@@H]3CCN(C)C3)=C(C=C2)C(F)(F)F
InChI
InChIKey=BPOWQJYAMDEAFF-CYBMUJFWSA-N
InChI=1S/C20H22BrF3N2O5S/c1-26-7-6-13(11-26)31-16-8-12(4-5-14(16)20(22,23)24)25-32(27,28)19-10-18(30-3)17(29-2)9-15(19)21/h4-5,8-10,13,25H,6-7,11H2,1-3H3/t13-/m1/s1
Molecular Formula | C20H22BrF3N2O5S |
Molecular Weight | 539.363 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15852036Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/22327329 | https://www.ncbi.nlm.nih.gov/pubmed/24340095
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15852036
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/22327329 | https://www.ncbi.nlm.nih.gov/pubmed/24340095
SB-706375 is a potent, surmountable, reversible and selective mammalian urotensin-II receptor antagonist. In rats SB-706375 provoked a pronounced diuresis and natriuresis, accompanied by modest increases in effective renal blood flow and glomerular filtration rate.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3764 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15852036 |
9.3 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375. | 2005 Jul |
|
Ontogeny of the renal urotensin II system in the rat. | 2012 Jun |
|
The urotensin system is up-regulated in the pre-hypertensive spontaneously hypertensive rat. | 2013 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15852036
SB-706375 (0.3–3.0 mM) is a competitive antagonist of urotensin-II-induced contraction of the rat isolated aorta
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:28:12 GMT 2023
by
admin
on
Sat Dec 16 14:28:12 GMT 2023
|
Record UNII |
96711H97SD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
96711H97SD
Created by
admin on Sat Dec 16 14:28:12 GMT 2023 , Edited by admin on Sat Dec 16 14:28:12 GMT 2023
|
PRIMARY | |||
|
21023902
Created by
admin on Sat Dec 16 14:28:12 GMT 2023 , Edited by admin on Sat Dec 16 14:28:12 GMT 2023
|
PRIMARY | |||
|
733734-61-7
Created by
admin on Sat Dec 16 14:28:12 GMT 2023 , Edited by admin on Sat Dec 16 14:28:12 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |